Early	B:C1856550
Development	I:C1856550
Challenges	B:C0805586
for	O
Drug	B:C0013227
Products	I:C0013227
Containing	O
Nanomaterials	O

The	O
vast	O
majority	O
of	O
drug	B:C0013227
product	I:C0013227
candidates	B:C1257890
in	O
early	B:C1856550
development	I:C1856550
fail	O
to	O
progress	O
to	O
clinics	B:C0442592
.	O

This	O
is	O
true	O
for	O
products	B:C0013227
containing	O
nanomaterials	O
just	O
as	O
for	O
other	O
types	O
of	O
pharmaceuticals	B:C1254351
.	O

Early	B:C1856550
development	I:C1856550
pathways	B:C0282654
should	O
therefore	O
place	O
high	O
priority	O
on	O
experiments	B:C0681814
that	O
help	O
candidates	B:C1257890
fail	O
faster	O
and	O
less	O
expensively	O
.	O

Some	O
of	O
the	O
points	O
of	O
failure	O
are	O
not	O
considerations	B:C0518609
in	O
the	O
development	O
of	O
small	B:C1328819
molecules	I:C1328819
or	O
biopharmaceuticals	B:C0005515
,	O
and	O
so	O
may	O
be	O
unexpected	O
,	O
even	O
to	O
those	O
with	O
previous	O
experience	B:C0596545
bringing	O
drug	B:C0013227
products	I:C0013227
to	O
the	O
clinic	B:C0442592
.	O

This	O
article	B:C1706852
reviews	B:C0282443
experiments	B:C0681814
that	O
have	O
proven	O
useful	O
in	O
providing	O
"	O
go	O
/	O
no	O
-	O
go	O
"	O
decision	O
-	O
making	O
data	O
for	O
nanomedicines	O
in	O
early	B:C1512070
preclinical	I:C1512070
development	I:C1512070
.	O

Of	O
course	O
,	O
the	O
specifics	O
depend	O
on	O
the	O
particulars	O
of	O
the	O
drug	B:C0013227
product	I:C0013227
and	O
the	O
nanomaterial	O
type	O
,	O
and	O
not	O
every	O
product	B:C0013227
shares	O
the	O
same	O
development	O
pathway	O
or	O
the	O
same	O
potential	O
points	O
of	O
failure	O
.	O

Here	O
,	O
we	O
focus	O
on	O
challenges	B:C0805586
that	O
differ	O
from	O
those	O
in	O
the	O
development	O
of	O
traditional	O
small	B:C1328819
molecule	I:C1328819
therapeutics	B:C1254351
,	O
and	O
on	O
experiments	B:C0681814
that	O
reveal	O
deficiencies	O
that	O
can	O
only	O
be	O
corrected	O
by	O
essentially	O
starting	O
over	O
-	O
altering	O
the	O
nanomedicine	O
to	O
an	O
extent	O
that	O
all	O
previous	O
characterization	O
and	O
proof	B:C0242481
-	I:C0242481
of	I:C0242481
-	I:C0242481
concept	I:C0242481
testing	I:C0242481
must	O
be	O
repeated	O
.	O

Conducting	O
these	O
experiments	B:C0681814
early	O
in	O
the	O
development	O
process	O
can	O
save	O
significant	O
resources	O
and	O
time	O
and	O
allow	O
developers	B:C1257890
to	O
focus	O
on	O
derisked	B:C1257890
candidates	I:C1257890
with	O
a	O
greater	O
likelihood	O
of	O
ultimate	O
success	O
.	O

